{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:37:46Z","timestamp":1792759066165,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T00:00:00Z","timestamp":1678752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T00:00:00Z","timestamp":1678752000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Continuous, objective monitoring of motor signs and symptoms may help improve tracking of disease progression and treatment response in Parkinson\u2019s disease (PD). This study assessed the analytical and clinical validity of multi-sensor smartwatch measurements in hospitalized and home-based settings (96 patients with PD; mean wear time 19\u00a0h\/day) using a twice-daily virtual motor examination (VME) at times representing medication OFF\/ON states. Digital measurement performance was better during inpatient clinical assessments for composite V-scores than single-sensor\u2013derived features for bradykinesia (Spearman |r|=\u20090.63, reliability\u2009=\u20090.72), tremor (|r|=\u20090.41, reliability\u2009=\u20090.65), and overall motor features (|r|=\u20090.70, reliability\u2009=\u20090.67). Composite levodopa effect sizes during hospitalization were 0.51\u20131.44 for clinical assessments and 0.56\u20131.37 for VMEs. Reliability of digital measurements during home-based VMEs was 0.62\u20130.80 for scores derived from weekly averages and 0.24\u20130.66 for daily measurements. These results show that unsupervised digital measurements of motor features with wrist-worn sensors are sensitive to medication state and are reliable in naturalistic settings.<\/jats:p><jats:p><jats:bold>Trial Registration:<\/jats:bold> Japan Pharmaceutical Information Center Clinical Trials Information (JAPIC-CTI): JapicCTI-194825; Registered June 25, 2019.<\/jats:p>","DOI":"10.1038\/s41598-023-29382-6","type":"journal-article","created":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T11:12:33Z","timestamp":1678792353000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Analytical and clinical validity of wearable, multi-sensor technology for assessment of motor function in patients with Parkinson\u2019s disease in Japan"],"prefix":"10.1038","volume":"13","author":[{"given":"Genko","family":"Oyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilien","family":"Burq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Hatano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"William J.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Kapur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jovelle","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Fujikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Furusawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Nakatome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Rainaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"King Chung","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikaru","family":"Kamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Oji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"Takeshige-Amano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuyuko","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Shiina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anri","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayu","family":"Ishiguro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Saiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Motohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutaka","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,14]]},"reference":[{"key":"29382_CR1","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia, L. V. & Lang, A. E. Parkinson\u2019s disease. Lancet 386, 896\u2013912 (2015).","journal-title":"Lancet"},{"key":"29382_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.117172","volume":"419","author":"K Kurihara","year":"2020","unstructured":"Kurihara, K. et al. Impact of motor and nonmotor symptoms in Parkinson disease for the quality of life: The Japanese Quality-of-Life Survey of Parkinson Disease (JAQPAD) study. J. Neurol. Sci. 419, 117172 (2020).","journal-title":"J. Neurol. Sci."},{"key":"29382_CR3","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.2147\/NDT.S304567","volume":"17","author":"MD Smith","year":"2021","unstructured":"Smith, M. D., Brazier, D. E. & Henderson, E. J. Current perspectives on the assessment and management of gait disorders in Parkinson\u2019s disease. Neuropsychiatr. Dis. Treat 17, 2965\u20132985 (2021).","journal-title":"Neuropsychiatr. Dis. Treat"},{"key":"29382_CR4","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1001\/jama.2014.3654","volume":"311","author":"BS Connolly","year":"2014","unstructured":"Connolly, B. S. & Lang, A. E. Pharmacological treatment of Parkinson disease: A review. JAMA 311, 1670\u20131683 (2014).","journal-title":"JAMA"},{"key":"29382_CR5","doi-asserted-by":"publisher","first-page":"232","DOI":"10.17294\/2330-0698.1836","volume":"8","author":"S Mantri","year":"2021","unstructured":"Mantri, S. et al. The experience of OFF periods in Parkinson\u2019s disease: Descriptions, triggers, and alleviating factors. J. Patient Cent. Res. Rev. 8, 232\u2013238 (2021).","journal-title":"J. Patient Cent. Res. Rev."},{"key":"29382_CR6","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz, C. G. et al. Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDSUPDRS): Scale presentation and clinimetric testing results. Mov. Disord. 23, 2129\u20132170 (2008).","journal-title":"Mov. Disord."},{"key":"29382_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/00002826-200003000-00003","volume":"23","author":"RA Hauser","year":"2000","unstructured":"Hauser, R. A. et al. A home diary to assess functional status in patients with Parkinson\u2019s disease with motor fluctuations and dyskinesia. Clin. Neuropharmacol. 23, 75\u201381 (2000).","journal-title":"Clin. Neuropharmacol."},{"key":"29382_CR8","first-page":"1765220","volume":"2021","author":"RM Hendricks","year":"2021","unstructured":"Hendricks, R. M. & Khasawneh, M. T. An investigation into the use and meaning of Parkinson\u2019s disease clinical scale scores. Parkinsons. Dis. 2021, 1765220 (2021).","journal-title":"Parkinsons. Dis."},{"key":"29382_CR9","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s00415-020-10350-3","volume":"269","author":"S Ancona","year":"2022","unstructured":"Ancona, S. et al. Wearables in the home-based assessment of abnormal movements in Parkinson\u2019s disease: A systematic review of the literature. J. Neurol. 269, 100\u2013110 (2022).","journal-title":"J. Neurol."},{"key":"29382_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0246528","volume":"16","author":"M Sica","year":"2021","unstructured":"Sica, M. et al. Continuous home monitoring of Parkinson\u2019s disease using inertial sensors: A systematic review. PLoS ONE 16, e0246528 (2021).","journal-title":"PLoS ONE"},{"key":"29382_CR11","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41746-022-00568-y","volume":"5","author":"AS Chandrabhatla","year":"2022","unstructured":"Chandrabhatla, A. S., Pomeraniec, I. J. & Ksendzovsky, A. Co-evolution of machine learning and digital technologies to improve monitoring of Parkinson\u2019s disease motor symptoms. NPJ. Digit. Med. 5, 32 (2022).","journal-title":"NPJ. Digit. Med."},{"key":"29382_CR12","doi-asserted-by":"publisher","first-page":"7354","DOI":"10.3390\/app11167354","volume":"11","author":"JN Victorino","year":"2021","unstructured":"Victorino, J. N., Shibata, Y., Inoue, S. & Shibata, T. Predicting wearing-off of Parkinson\u2019s disease patients using a wristworn fitness tracker and a smartphone: A case study. Appl. Sci. 11, 7354 (2021).","journal-title":"Appl. Sci."},{"key":"29382_CR13","doi-asserted-by":"publisher","first-page":"7876","DOI":"10.3390\/s21237876","volume":"21","author":"JGV Habets","year":"2021","unstructured":"Habets, J. G. V. et al. Rapid dynamic naturalistic monitoring of bradykinesia in Parkinson's disease using a wrist-worn accelerometer. Sensors (Basel) 21, 7876 (2021).","journal-title":"Sensors (Basel)"},{"key":"29382_CR14","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jneumeth.2011.09.019","volume":"203","author":"TO Mera","year":"2012","unstructured":"Mera, T. O., Heldman, D. A., Espay, A. J., Payne, M. & Giuffrida, J. P. Feasibility of home-based automated Parkinson\u2019s disease motor assessment. J. Neurosci. Methods 203, 152\u2013156 (2012).","journal-title":"J. Neurosci. Methods"},{"key":"29382_CR15","doi-asserted-by":"publisher","DOI":"10.2196\/16414","volume":"8","author":"D Gatsios","year":"2020","unstructured":"Gatsios, D. et al. Feasibility and utility of mHealth for the remote monitoring of Parkinson disease: Ancillary study of the PD_manager randomized controlled trial. JMIR Mhealth Uhealth 8, e16414 (2020).","journal-title":"JMIR Mhealth Uhealth"},{"key":"29382_CR16","doi-asserted-by":"crossref","unstructured":"Powers, R. et al. Smartwatch inertial sensors continuously monitor real-world motor fluctuations in Parkinson's disease. Sci. Transl. Med. 13, eabd7865 (2021).","DOI":"10.1126\/scitranslmed.abd7865"},{"key":"29382_CR17","doi-asserted-by":"crossref","unstructured":"Silva de Lima, A. L. et al. Feasibility of large-scale deployment of multiple wearable sensors in Parkinson's disease. PLoS One 12, e0189161 (2017).","DOI":"10.1371\/journal.pone.0189161"},{"key":"29382_CR18","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1089\/tmj.2021.0489","volume":"28","author":"T Sakamaki","year":"2022","unstructured":"Sakamaki, T., Furusawa, Y., Hayashi, A., Otsuka, M. & Fernandez, J. Remote patient monitoring for neuropsychiatric disorders: A scoping review of current trends and future perspectives from recent publications and upcoming clinical trials. Telemed. J. E Health 28, 1235\u20131250\u00a0(2022).","journal-title":"Telemed. J. E Health"},{"key":"29382_CR19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41746-022-00607-8","volume":"5","author":"M Burq","year":"2022","unstructured":"Burq, M. et al. Virtual exam for Parkinson\u2019s disease enables frequent and reliable remote measurements of motor function. NPJ. Digit. Med. 5, 65 (2022).","journal-title":"NPJ. Digit. Med."},{"key":"29382_CR20","unstructured":"FDA-NIH Biomarker Working Group. BEST (Biomarkers, EndpointS, and other Tools) Resource. Silver Spring (MD) and Bethesda (MD): Food and Drug Administration and National Institutes of Health; 2021."},{"key":"29382_CR21","unstructured":"Evers, L. et al. Long-term adherence with wearing a multi-sensor watch in the Personalized Parkinson Project [abstract]. Mov Disord 34 (suppl 2) (2019). https:\/\/www.mdsabstracts.org\/abstract\/long-term-adherence-with-wearing-a-multi-sensor-watch-in-the-personalized-parkinson-project\/. Accessed September 28, 2021."},{"key":"29382_CR22","doi-asserted-by":"publisher","first-page":"5169","DOI":"10.3390\/s19235169","volume":"19","author":"A Botros","year":"2019","unstructured":"Botros, A. et al. Long-term home-monitoring sensor technology in patients with Parkinson's disease-acceptance and adherence. Sensors (Basel) 19,  5169 (2019).","journal-title":"Sensors (Basel)"},{"key":"29382_CR23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1089\/tmj.2015.0026","volume":"22","author":"JM Fisher","year":"2016","unstructured":"Fisher, J. M., Hammerla, N. Y., Rochester, L., Andras, P. & Walker, R. W. Body-worn sensors in Parkinson\u2019s disease: Evaluating their acceptability to patients. Telemed. J. E Health 22, 63\u201369 (2016).","journal-title":"Telemed. J. E Health"},{"key":"29382_CR24","doi-asserted-by":"publisher","first-page":"631","DOI":"10.3233\/JPD-160830","volume":"6","author":"DA Heldman","year":"2016","unstructured":"Heldman, D. A., Giuffrida, J. P. & Cubo, E. Wearable sensors for advanced therapy referral in parkinson\u2019s disease. J. Parkinsons. Dis. 6, 631\u2013638 (2016).","journal-title":"J. Parkinsons. Dis."},{"key":"29382_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1159\/000475801","volume":"1","author":"DA Heldman","year":"2017","unstructured":"Heldman, D. A. et al. Telehealth management of Parkinson\u2019s disease using wearable sensors: An exploratory study. Digit. Biomark. 1, 43\u201351 (2017).","journal-title":"Digit. Biomark."},{"key":"29382_CR26","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.parkreldis.2019.01.025","volume":"64","author":"SH Isaacson","year":"2019","unstructured":"Isaacson, S. H. et al. Effect of using a wearable device on clinical decision-making and motor symptoms in patients with Parkinson\u2019s disease starting transdermal rotigotine patch: A pilot study. Parkinsonism Relat. Disord. 64, 132\u2013137 (2019).","journal-title":"Parkinsonism Relat. Disord."},{"key":"29382_CR27","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1109\/TBME.2017.2697764","volume":"65","author":"CL Pulliam","year":"2018","unstructured":"Pulliam, C. L. et al. Continuous assessment of levodopa response in Parkinson\u2019s disease using wearable motion sensors. IEEE Trans. Biomed. Eng. 65, 159\u2013164 (2018).","journal-title":"IEEE Trans. Biomed. Eng."},{"key":"29382_CR28","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1002\/mds.27431","volume":"33","author":"D Berg","year":"2018","unstructured":"Berg, D. et al. Movement disorder society criteria for clinically established early Parkinson\u2019s disease. Mov. Disord. 33, 1643\u20131646 (2018).","journal-title":"Mov. Disord."},{"key":"29382_CR29","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/ageing\/26.5.353","volume":"26","author":"C Jenkinson","year":"1997","unstructured":"Jenkinson, C., Fitzpatrick, R., Peto, V., Greenhall, R. & Hyman, N. The Parkinson\u2019s Disease Questionnaire (PDQ-39): Development and validation of a Parkinson\u2019s disease summary index score. Age Ageing 26, 353\u2013357 (1997).","journal-title":"Age Ageing"},{"key":"29382_CR30","first-page":"152","volume-title":"Third symposium on Parkinson\u2019s disease","author":"RS Schwab","year":"1969","unstructured":"Schwab, R. S. & England, A. C. Projection technique for evaluating surgery in Parkinson\u2019s disease. In Third symposium on Parkinson\u2019s disease (eds Gillingham, F. J. & Donaldson, M. C.) 152\u2013157 (Livingston, 1969)."},{"key":"29382_CR31","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/ana.25548","volume":"86","author":"S Del Din","year":"2019","unstructured":"Del Din, S. et al. Gait analysis with wearables predicts conversion to parkinson disease. Ann. Neurol. 86, 357\u2013367 (2019).","journal-title":"Ann. Neurol."},{"key":"29382_CR32","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41746-019-0217-7","volume":"3","author":"N Mahadevan","year":"2020","unstructured":"Mahadevan, N. et al. Development of digital biomarkers for resting tremor and bradykinesia using a wrist-worn wearable device. NPJ. Digit. Med. 3, 5 (2020).","journal-title":"NPJ. Digit. Med."},{"key":"29382_CR33","doi-asserted-by":"publisher","first-page":"5963","DOI":"10.3390\/s20205963","volume":"20","author":"E Warmerdam","year":"2020","unstructured":"Warmerdam, E. et al. Quantification of arm swing during walking in healthy adults and Parkinson's disease patients: Wearable sensor-based algorithm development and validation. Sensors (Basel) 20, 5963 (2020).","journal-title":"Sensors (Basel)"},{"key":"29382_CR34","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1007\/s11517-017-1621-2","volume":"55","author":"B Fasel","year":"2017","unstructured":"Fasel, B. et al. A wrist sensor and algorithm to determine instantaneous walking cadence and speed in daily life walking. Med. Biol. Eng. Comput. 55, 1773\u20131785 (2017).","journal-title":"Med. Biol. Eng. Comput."},{"key":"29382_CR35","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1109\/JBHI.2019.2914940","volume":"24","author":"A Soltani","year":"2020","unstructured":"Soltani, A., Dejnabadi, H., Savary, M. & Aminian, K. Real-world gait speed estimation using wrist sensor: A personalized approach. IEEE J. Biomed. Health Inform. 24, 658\u2013668 (2020).","journal-title":"IEEE J. Biomed. Health Inform."},{"key":"29382_CR36","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.2522\/ptj.20150580","volume":"96","author":"FB Horak","year":"2016","unstructured":"Horak, F. B., Mancini, M., Carlson-Kuhta, P., Nutt, J. G. & Salarian, A. Balance and gait represent independent domains of mobility in Parkinson disease. Phys. Ther. 96, 1364\u20131371 (2016).","journal-title":"Phys. Ther."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29382-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29382-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29382-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T11:17:26Z","timestamp":1678792646000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29382-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,14]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["29382"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-29382-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,14]]},"assertion":[{"value":"13 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.H. has received grants from: the Japan Agency for Medical Research and Development (grant numbers: 20dm0107156, 21wm0425015, 21ak0101112, and 21dk0207055), the Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research (grant number: 21K07424), the Setsuro Fujii Memorial Osaka Foundation for Promotion of Fundamental Medical Research, and Daiichi Sankyo TaNeDS; and research funds from: Daiichi Sankyo TaNeDS Funding Program. He has received speaker\u2019s honoraria from: Sumitomo Dainippon Pharma Co. Ltd., Takeda Pharmaceutical Company Limited, FP Pharmaceutical Corporation, Kyowa Kirin Co., Ltd., Nihon Medi-Physics Co., Ltd., Novartis Pharma K.K., Ono Pharmaceutical Co., Ltd, and Otsuka Pharmaceutical Co., Ltd. N.N. has received grants from Grant-in-Aid for Scientific Research (Kakenhi) and Sumitomo Dainippon Pharma Co. Ltd. and honoraria from Sumitomo Dainippon Pharma Co. Ltd., Takeda Pharmaceutical Company Limited, AbbVie GK, Kyowa Kirin Co., Ltd., and Ono Pharmaceutical Co., Ltd. N.H. has received consulting fees from GlaxoSmithKline K.K., AbbVie Inc., Eisai Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Sumitomo Dainippon Pharma Co. Ltd., Kyowa Kirin Co., Ltd., Hisamitsu Pharmaceutical Co., Inc., Meiji Seika Pharma Co., Ltd., Ono Pharmaceutical Co., Ltd, and FP Pharmaceutical Corporation; lecture fees from MSD K.K., Eli Lilly Japan K.K., Eisai Co., Ltd., FP Pharmaceutical Corporation, Otsuka Pharmaceutical Co., Ltd., Tsumura & Co., Kyowa Kirin Co., Ltd., GlaxoSmithKline K.K., Takeda Pharmaceutical Company Limited, Mitsubishi Tanabe Pharma Corporation, Nihon Medi-Physics Co., Ltd., Novartis Pharma K.K., Pfizer Japan Inc., Nippon Boehringer Ingelheim Co., Ltd., Sumitomo Dainippon Pharma Co. Ltd., and Daiichi Sankyo Company, Limited; honoraria from FP Pharmaceutical Corporation, Novartis Pharma K.K., Kyowa Kirin Co., Ltd., and AbbVie Inc.; research support from Otsuka Pharmaceutical Co., Ltd.; and grants from Astellas Pharma Inc., Eisai Co., Ltd., GlaxoSmithKline K.K., Sumitomo Dainippon Pharma Co. Ltd., Takeda Pharmaceutical Company Limited, Novartis Pharma K.K., Pfizer Japan Inc., Kyowa Kirin Co., Ltd., Medtronic Japan Co., Ltd., Nippon Boehringer Ingelheim Co., Ltd., Boston Scientific Corporation, Kissei Pharmaceutical Co., Ltd, and Otsuka Pharmaceutical Co., Ltd. G.O. has received grants from Grant-in-Aid for Scientific Research (Kakenhi) and Novartis Pharma K.K. and honoraria from AbbVie Inc., Boston Scientific Corporation, Eisai Co., Ltd., Kyowa Kirin Co., Ltd., Medtronic Japan Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Sumitomo Dainippon Pharma Co. Ltd., and Takeda Pharmaceutical Company Limited. A.Hat, M.I., H.K., R.N., T.O., Y.O., F.S., K.S., H.T.-A., D.T., S.S., and S.U. have no conflicts of interest to disclose. M.B., C.C., K.C.S., R.K., W.J.M., and E.R. are employees and minor shareholders of Verily Life Sciences LLC. K.F., Y.F., A.Hay, M.M., and K.N. are employees of Takeda Pharmaceutical Company Limited. J.F. was an employee of Takeda at the time the work was conducted and is a minor shareholder of Takeda and GlaxoSmithKline.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3600"}}